GSK/Vir’s Covid Antibody Gains EU Clearance, But Demand May Have Peaked

Vaccinations Will Weaken Demand

21 May 2021

The green light for the COVID-19 antibody therapy is welcome news for the partners, but rising vaccination rates plus three other competitors in Europe will limit revenues.

Paris, 19 May 2021: cafes and restaurants have reopened in France and other EU nations as vaccinations help to cut cases and reduce transmission. • Source: Getty Images

GSK/Vir’s Covid Antibody Gains EU Clearance, But Demand May Have Peaked

Vaccinations Will Weaken Demand

More from COVID-19

More from Scrip